Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Dynatronics (DYNT) PT Lowered to $2 at Maxim Group, Following Earnings
-
Maxim Group Downgrades Cassava Sciences (SAVA) to Hold
-
Pre-Open Movers 05/15: (SRNE) (NEWR) (DENN) Higher; (SAVA) (JCP) (CODX) Lower (more...)
-
Top Ships (TOPS) Prices 59.4M Share Registered Direct Offering at $0.135/Sh
-
TOP Ships Inc. Announces Pricing of $8.0 Million Common Shares Registered Direct Offering
-
Maxim Group Upgrades Onconova Therapeutics (ONTX) to Buy
-
Esports Entertainment Group Announces Partial Exercise of Over-Allotment Option
-
Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update
-
Cidara Provides Corporate Update and Reports First Quarter 2020 Financial Results
-
Capricor Therapeutics (CAPR) PT Raised to $12 at Maxim Group
-
Aridis Pharmaceuticals Announces First Quarter 2020 Results
-
UPDATE: Color Star Technology Co. (HHT) Prices $1.43M Registered Direct Offering
-
Color Star Technology Announces Pricing of Approximately $1.43 million Registered Direct Offering
-
APPlife Digital Solutions, Inc. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
-
Biometric Solutions Provider BIO-key Raises $2.1M in Private Placement of a Senior Secured Convertible Note
-
CECO Environmental (CECE) PT Lowered to $7 at Maxim Group, Following Earnings
-
Seanergy Maritime (SHIP) Prices $5.2M Share Registered Direct Offering
-
Seanergy Maritime Holdings Corp. Announces Pricing of Additional $5.2 Million Offering
-
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference
-
Maxim Group Upgrades American Capital Agency (AGNC) to Buy
-
Appili Therapeutics to Present at Maxim Group’s Infectious Disease Virtual Conference
-
Appili Therapeutics to Present at Maxim Group’s Infectious Disease Virtual Conference
-
Maxim Group LLC Announces Infectious Disease Virtual Conference to Be Hosted by M-Vest
-
Digirad Announces Updates on its Key Growth and Value Enhancement Initiatives
-
UPDATE: IT Tech Packaging (ITP) Prices 4.4M Share Registered Direct Offering for Approx. $2.6M
-
Seanergy Maritime (SHIP) Announces Pricing of Approximately $5.2 Million Offering of Common Shares, Warrants
-
IT Tech Packaging Announces Pricing of Approximately $2.6 million Registered Direct Offering
-
Seanergy Maritime Holdings Corp. Announces Pricing of Approximately $5.2 Million Offering
-
Capricor Therapeutics (CAPR) PT Raised to $10 at Maxim Group, After COVID-19 Drug Study Results
-
Top Ships (TOPS) Announces Pricing of Additional $5.5 Million Common Shares Registered Direct Offering
-
TOP Ships Inc. Announces Pricing of Additional $5.5 Million Common Shares Registered Direct Offering
-
Aptorum Group Limited to Present at the Infectious Disease Virtual Conference
-
Amplyx Pharmaceuticals to Participate in Antifungal Panel at Maxim Group's Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
-
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference
-
AIM ImmunoTech’s CEO to Present at Maxim’s Infectious Disease Virtual Conference
-
Aridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual Conference
-
Seanergy Maritime (SHIP) PT Lowered to $0.40 at Maxim Group
-
Top Ships (TOPS) Announces Pricing of $6.5 Million Common Shares Registered Direct Offering
-
INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5, 2020
-
TOP Ships Inc. Announces Pricing of $6.5 Million Common Shares Registered Direct Offering
-
INmune Bio, Inc. to Speak on COVID-19 Therapeutic Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5, 2020
-
Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector
-
Daré Bioscience CEO to Participate in Maxim Group’s Infectious Disease Virtual Conference
-
Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference
-
SCYNEXIS to Participate in Antifungals Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
-
Matinas BioPharma to Participate in Panel Discussion During Maxim Group Infectious Disease Virtual Conference
-
Matinas BioPharma to Participate in Panel Discussion During Maxim Group Infectious Disease Virtual Conference
-
Actinium Pharmaceuticals, Inc. Announces Closing of $31.6 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Summit Wireless Technologies Announces Closing of $6.5 Million Underwritten Public Offering
-
Summit Wireless Technologies (WISA) Prices 2M Share Common Offering at $3.25/Sh

